课题基金 / 基金详情

Isolation of T-cell clones cytotoxic agcirst nemotopoietic progenitor cells from a patienl with aplastic aremia

Isolation of T-cell clones cytotoxic agcirst nemotopoietic progenitor cells from a patienl with aplastic aremia
从患有再生障碍性贫血的患者中分离细胞毒性主动造血祖细胞的 T 细胞克隆
批准号:
06671080
负责人:
NAKAO Shinji
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKAO Shinji的其他基金

相似基金

相关文献

中文摘要
翻译
虽然免疫介导的造血抑制一直被认为是特发性再生障碍性贫血发生的最重要机制,但尚未获得这种免疫攻击的直接证据。为了确定可能导致骨髓衰竭发展的T淋巴细胞,我们从一名未融合的再生障碍性贫血患者的骨髓中建立了T细胞克隆,该患者拥有HLA-DRB1^<**>1501和DRB1^<**>0405。在分离的CD4^+T细胞克隆中,一个Vbeta21 T细胞克隆NT4.2不仅能对照射的自体CD34^+细胞或EBV转化的淋巴母细胞系(LCL)产生干扰素-γ,而且还能裂解具有人类白细胞抗原-DRB1^和同种异体LCL的自体LCL和异体LCL。Vbeta21基因扩增产物的单链构象多态性分析表明,NT4.2是患者骨髓中Vbeta21^+T细胞中最具优势的克隆。加入抗人类白细胞抗原-DR单抗或抗CD3单抗可阻断NT4.2对LCL细胞的杀伤作用。当CD34^+细胞在各种集落刺激因子存在下培养一周后,NT4.2细胞也能裂解自体CD34^+细胞和拥有HLADRB1;**>0405的正常人的同种异体CD34^+细胞。当NT4.2细胞与培养的CD34^+细胞共同孵育时,NT4.2细胞强烈抑制自体造血祖细胞或带有HLA-DRB1^<**>0405的同种异体祖细胞的集落形成。这些发现提示,这种T细胞克隆可能通过识别与人类白细胞抗原DR4结合的造血祖细胞上的一种自体多肽而参与再生障碍性贫血的造血抑制。
英文摘要
Although immune-mediated suppression of hematopoiesis has been considered to be the most important mechanism for the development of idiopathic aplastic anemia, direct evidence for such immunologic attack has not been obtained. To identify T lymphocytes that may contribute to the development of bone marrow failure, we established T-cell clones from the bone marrow of an untrasnfused patient with aplastic anemia, who owned HLA-DRB1^<**>1501 and DRB1^<**>0405. Among CD4^+ T-cell clones isolated, a Vbeta21 T-cell clone, NT4.2, not only secreted interferon-gamma in response to irradiated autologous CD34^+ cells or EBV-transformed lymphoblastoid cell line (LCL) but also lysed the autologous LCL and allogneic LCL owning HLA-DRB1^<**>0405. Single strand conformation polymorphism analysis of amplified Vbeta21 cDNA products revealed that NT4.2 was the most dominant clone among Vbeta21^+ T cells in the bone marrow of the patient. The cytotoxicity against LCL cells by NT4.2 was blocked by the addition of anti HLA-DR monoclonal antibodies (mAb) or anti CD3 mAb into the culture. NT4.2 cells also lysed autologous CD34^+ cells as well as allogeneic CD34^+ cells of a normal individual owining HLA-DRB1^<**>0405 when the CD34^+ cells were cultured in the presence of various colony-stimulaing factors for one week prior to the ^<51>Cr release assay. The NT4.2 cells strongly inhibited colony formation by autologous hematopoietic progenitor cells or by the allogeneic progenitor cells with HLA-DRB1^<**>0405 when they were incubated with the cultured CD34^+ cells prior to plating with the methylcellulose medium. These findings suggest that this T-cell clone may contribute to the suppression of hematopoiesis in aplastic anemia by recognizing a self-peptide on hematopoietic progenitor cells bound to HLA-DR4.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Nakao S et al: "Estoblichment of a CD4^+ T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated oplastic anemia" Exp. Hematol. 23. 433-438 (1995)
Nakao S 等人:“识别来自免疫介导的肿瘤性贫血患者的自体造血祖细胞的 CD4^T 细胞克隆的建立”实验。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakao S et al.: "Establishment of a CD^+_4 T cell clone recogniing autologous hematopcietic progenitor cells from a patient with immume-meceiated oplastic" Experimental Hematology,. (1995)
Nakao S等人:“建立识别来自免疫浆化肿瘤患者的自体造血祖细胞的CD^_4 T细胞克隆”实验血液学,。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakao S.et al.: "Establichment of a CD4^+ T cell clone recognizing autologous hematopoietic progenitor cells from a potient with immune-mediated aglastic anemia" Experimental Hematology. 23. 433-438 (1995)
Nakao S.等人:“建立识别来自免疫介导的无再生性贫血患者的自体造血祖细胞的 CD4+ T 细胞克隆”实验血液学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakao S.et al.: "Establishment of a CD4^+ T cell clone recognizing autologous henatopoietic progenitor cells from a patient with immune-mediated aplastic anemia" Experimental Hematology. 23. 433-438 (1995)
Nakao S.et al.:“建立识别来自免疫介导的再生障碍性贫血患者的自体造血祖细胞的 CD4^ T 细胞克隆”实验血液学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
  • 批准号:
    19H03686
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.23万
  • 财政年份:
    2019
  • 负责人:
    NAKAO Shinji
  • 依托单位:
Identification of cytokines responsible for the development of immune-mediated bone marrow failure using gene expression analyses of patients with aplastic anemia
  • 批准号:
    25670448
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2013
  • 负责人:
    NAKAO Shinji
  • 依托单位:
Identification of myelosuppressive cytokines taking advantage of genomic abnormalities of leukocytes in patients with aplastic anemia
  • 批准号:
    24390243
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.48万
  • 财政年份:
    2012
  • 负责人:
    NAKAO Shinji
  • 依托单位:
Identification of auto-antigens in acquired aplastic anemia associated with clonal hematopoiesis by hematopoietic stem cells with uniparental disomy of chromosome 6p
  • 批准号:
    23659486
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2011
  • 负责人:
    NAKAO Shinji
  • 依托单位:
海外基金